Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSurface Transforms Regulatory News (SCE)

  • This share is currently suspended. It was suspended at a price of 0.112
  • There is currently no data for SCE

Open Offer Excess

26 Jul 2017 11:21

RNS Number : 1518M
Surface Transforms PLC
26 July 2017
 

The information communicated within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

26 July 2017

 

Surface Transforms Plc.

("Surface Transforms" or the "Company")

 

Open Offer Excess

 

Subsequent to the Open Offer of July 6 and as announced on July 25, applications were received for 5,091,616 Open Offer Shares, representing a take-up of 157.84 per cent that was scaled back to 3,225,806 Open Offer Shares. The Company also announced that it was exploring alternative avenues to satisfy this additional excess demand.

 

The Board is able to use its discretionary powers to issue up to 10% of the share capital in any year, as granted by shareholders  at the general meeting of the Company held yesterday, and intends to use this authority to offer to allot 1,865,810 shares at 15.5p per share to those shareholders who applied for an excess of their entitlement in the Open Offer but were scaled back on their applications.

 

As a result up to 1,865,810 new ordinary shares of 1 pence each in the Company ("Ordinary Shares") will be admitted to trading on 10 August 2017.

 

To this end the Company is writing to this limited number of shareholders and asking them to inform the Company if they do not wish to continue with their Open Offer application. The Company is asking shareholders to reply by Wednesday August 8th and that if no reply is received the Company will assume that the shareholder has accepted the proposal and confirmed their wish to apply for new ordinary shares as aforesaid and will allot the shares by using the funds held on the Registrars.

 

For further information, please contact:

 

Surface Transforms plc.

 

Kevin Johnson, CEO +44 151 356 2141

David Bundred, Chairman

 

Cantor Fitzgerald Europe (Nomad & Joint Broker) 

 

David Foreman, Michael Reynolds (Corporate Finance) +44 20 7894 7000

Mark Westcott, Alex Pollen (Sales)

 

finnCap Ltd (Joint Broker)

 

Stephen Norcross, Richard Chambers (Corporate Broking) +44 20 7220 0500

Ed Frisby, Giles Rolls (Corporate Finance)

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
OUPBQLFLDDFFBBQ
Date   Source Headline
1st May 20207:00 amRNSResult of over-subscribed open offer
24th Apr 20204:17 pmRNSHolding(s) in Company
23rd Apr 202011:35 amEQSHardman & Co Research: Q&A with Mike Foster on Surface Transforms (SCE): High visibility for 2021 onwards; equity raise
21st Apr 20207:00 amRNSOpen Offer application form - update
20th Apr 202010:20 amRNSHolding(s) in Company
17th Apr 20203:15 pmEQSHardman & Co Research: Surface Transforms (SCE): High visibility for 2021 onwards; equity raise
9th Apr 20203:00 pmRNSPlacing and Open Offer
27th Mar 20207:00 amRNSDeferral of Publication of Results &COVID19 Update
28th Feb 20207:00 amRNSUnaudited interims for the 6 m/e 30 November 2019
10th Feb 20208:27 amRNSHolding(s) in Company
28th Jan 20205:30 pmRNSAppointment of Sales Director and Grant of Options
27th Jan 20202:00 pmRNSDirector/PDMR Shareholding
10th Jan 20207:00 amRNSTrading and operational update
5th Dec 20197:00 amRNSGrant of options
13th Nov 20198:33 amRNSExercise of options
13th Nov 20198:27 amRNSResult of AGM
6th Nov 201910:01 amRNSHolding(s) in Company
6th Nov 20199:00 amRNSExercise of Options and PDMR Dealing
25th Oct 201912:56 pmEQSHardman & Co Research : Surface Transforms (SCE): Recent major contract wins transform prospects
17th Oct 20197:00 amRNSPosting of Annual Report and Notice of AGM
2nd Oct 201910:55 amRNSDirector/PDMR Shareholding
26th Sep 20197:00 amRNSContract award from OEM 1
19th Sep 20197:00 amRNSCapital Markets Day
18th Sep 201910:50 amRNSHolding(s) in Company
9th Sep 20197:00 amRNSPreliminary results and notice of AGM
5th Sep 20194:10 pmEQSHardman & Co Research: Surface Transforms (SCE): Rapid acceleration - 'game-change' announcements
27th Aug 20197:00 amRNSContract Agreement with German OEM 5
15th Aug 20197:00 amRNSChange of Financial Year End Date
16th Jul 20197:00 amRNSContract award from German OEM 5
28th Jun 20197:00 amRNSContract Awards and Commercial Settlement
16th May 20197:00 amRNSDirector/PDMR Shareholding
7th May 20199:05 amRNSSecond Price Monitoring Extn
7th May 20199:00 amRNSPrice Monitoring Extension
7th May 20197:00 amRNSTrading Update
28th Mar 20197:00 amRNSDirector/PDMR Shareholding
25th Mar 20195:05 pmRNSHolding(s) in Company
20th Mar 20197:00 amRNS£1.9 million placing
26th Feb 20197:00 amRNSInterim Results
11th Dec 20185:36 pmRNSResult of AGM
6th Dec 20187:00 amRNSExercise of Options and Director Dealing
5th Dec 20187:00 amRNSGrant of Options
4th Dec 20187:00 amRNSTrading & Operational Update
17th Sep 20187:00 amRNSPreliminary Results and Notice of AGM
10th Sep 20187:00 amRNSBoard appointment
4th Jul 20183:19 pmRNSGrant of options
3rd Jul 20187:00 amRNSHolding(s) in Company
27th Jun 20188:38 amRNS£1.5 Million Placing
13th Jun 20187:00 amRNSPre Close Trading, Customer and Operations Update
10th May 20187:00 amRNSDirector/PDMR Shareholding
12th Apr 20187:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.